Home / Guidelines & Resources / Pulmonary Vascular Disease

Pulmonary Vascular Disease

CHEST’s pulmonary vascular disease resources help guide clinicians in providing the highest-quality care for patients with these conditions. Access original research from the journal CHEST^®, clinical practice guidelines, CHEST Physician articles, podcasts, video lectures, and educational courses and events.

CHEST Journal Highlights

Validation of a Noninvasive Assessment of Pulmonary Gas Exchange During Exercise in Hypoxia

By Connor A. Howe, BHK; David B. MacLeod, MD; Liisa Wainman, MSc; Samuel J. Oliver, PhD; and Philip N. Ainslie, PhD
October 2020 Issue
Pulmonary gas exchange efficiency traditionally is assessed through measurements of ventilation and end-tidal gases paired with direct arterial blood gas sampling. Researchers examined whether a noninvasive method of assessing pulmonary gas exchange is valid during rest and exercise in acute hypoxia.

Echocardiography-Derived Stroke Volume Index Is Associated With Adverse In-Hospital Outcomes in Intermediate-Risk Acute Pulmonary Embolism

By Graeme Prosperi-Porta, MD; Kevin Solverson, MD; Nowell Fine, MD; Christopher J. Humphreys, MD; André Ferland, MD; and Jason Weatherald, MD
September 2020 Issue
There remains uncertainty in the optimal prognostication and management of patients with intermediate-risk pulmonary embolism (PE). Is echocardiographic-derived stroke volume index associated with death or cardiopulmonary decompensation in intermediate-risk patients with PE?

Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD

By Aparna Balasubramanian, MD; Todd M. Kolb, MD, PhD; Rachel L. Damico, MD, PhD; Paul M. Hassoun, MD; Meredith C. McCormack, MD; and Stephen C. Mathai, MD
August 2020 Issue
Patients with COPD who experience pulmonary hypertension have worse mortality than those with COPD alone; however, predictors of poor outcomes in COPD-PH are not well-described. This study used a single-center registry to evaluate diffusing capacity of the lung as a predictor of mortality in a cohort of patients with COPD-PH.

VISUAL ABSTRACT

Evaluating Pulmonary Hypertension Following Aortic Valve Replacement

Can adding right heart chamber measurements to severity of pulmonary hypertension predict mortality in patients undergoing aortic valve replacement?

VIEW THE PDF

Upcoming Virtual Event

Comprehensive Review in Pulmonary Hypertension

Start the new year on the right track by staying up-to-date on your clinical knowledge. This online course will take place in the evening to better suit your schedule and minimize time away from your practice.

Chair: Namita Sood, MBBCh, FCCP
Dates: January 27, 2021, and February 3, 2021
Time: 5:00 pm – 7:00 pm CT

Notify me when registration opens »

CHEST Pulse Podcast

Virchow’s Triad and the Perfect Storm: VTE in Patients With COVID-19

Ryan Maves, MD, FCCP, interviews authors of the “Prevention, Diagnosis, and Treatment of Venous Thromboembolism in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report.”

Moderator: Ryan Maves, MD, FCCP
Panelists: Lisa Baumann Kreuziger, MD; David Jimenez, MD, PhD; Lisa K. Moores, MD, FCCP; and Tobias Tritschler, MD

Also available:

Guidelines

Get evidence-based information for enhancing patient care with CHEST’s pulmonary vascular guidelines and expert panel reports.

Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019

Therapy for Pulmonary Arterial Hypertension in Adults

Antithrombotic Therapy for Atrial Fibrillation

ALL PULMONARY VASCULAR GUIDELINES

Patient Information

The CHEST Foundation creates trusted patient education resources that empower patients to engage in better managing their health.

Pulmonary Arterial Hypertension
Pulmonary Vascular Disease
Pulmonary Hypertension

e-Learning Courses

Gain access to pulmonary vascular disease e-learning materials with a subscription to CHEST’s e-Learning Library.

Managing the Patient with PAH: A Customized Approach

Review practical approaches to a number of common PAH management challenges and areas of continued and ongoing research.

CME Available: 2.0 AMA PRA Category 1 Credits^™

Access now »

InPHOCUS Pulmonary Hypertension Self-Study Module

This module focuses on effective pulmonary hypertension diagnosis, personalized assessment, and treatment with an emphasis on PAH and CTEPH.

CME Available: 2.5 AMA PRA Category 1 Credits^™

Complete the module »

Management of Acute Pulmonary Embolism: Pro/Con Debates

Learn how and when to utilize catheter-based therapy, oral anticoagulant agents, and thrombolytic therapy in patients with pulmonary embolism.

CME Available: 1.0 AMA PRA Category 1 Credits^™

Listen to the debate »

CHEST E-LEARNING LIBRARY Customize a learning plan specific to your needs. SUBSCRIBE NOW »

Latest News From CHEST Physician

COVID-19 & Pulmonary Vasculature—An Intriguing Relationship

By Humna Abid Memon, MD
Fellow-in-Training Member, Pulmonary Vascular Disease NetWork Steering Committee
Dr. Memon highlights recent literature on the complex and multifaceted relationship between COVID-19 and pulmonary vasculature, which may prove to be insightful for discovering potential therapeutic targets in COVID-19.

From the NetWorks

Jean Elwing, MD, FCCP

Jean Elwing, MD, FCCP
Chair, Pulmonary Vascular Disease NetWork

Get the latest updates from CHEST’s Pulmonary Vascular Disease NetWork.

READ NETWORK NEWS

CHEST CLINICAL PERSPECTIVES^™

State of Practice: Management Practice for Thromboprophylaxis in Acutely Ill Medical Patients

This report explores the results of a survey of pulmonologists and intensivists regarding their approach to ordering thromboprophylaxis in acutely ill medical patients for the purpose of reducing risk of venous thromboembolism.

Pulmonary Vascular Lecture

PAH Risk Assessment: Overview and Review of PVD NetWork Survey

Vijay Balasubramanian, MD, FCCP, Medical Director of Pulmonary Hypertension-Community Regional Medical Center at UCSF Fresno, and Jean Elwing, MD, FCCP, Director of the Pulmonary Hypertension Program at the University of Cincinnati Health in Ohio, discuss the results of the Pulmonary Vascular Disease NetWork’s survey on how clinicians have implemented risk assessment tools to evaluate and monitor patients with pulmonary arterial hypertension.

Pulmonary Vascular Disease Sessions at CHEST 2020

The annual meeting may be over, but the high-quality pulmonary vascular disease sessions are still available. CHEST 2020 registrants have continued access to live session recordings and all prerecorded material until January 2021. Watch sessions such as:

Diagnostics and Management of Pulmonary Hypertension: What NOT to Do…
After the Acute Pulmonary Embolism: What Now? A Case-based Discussion
Too Much of a Good Thing or Not Enough? Treating Scleroderma With ILD and PH: A Pro-Con Debate
The Crashing Pulmonary Arterial Hypertension Patient: An Intensivist’s Nightmare

CONTINUE THE CHEST 2020 EXPERIENCE

MISS THE MEETING? GET ACCESS NOW!

Join the Conversation

Have an idea or suggestion? See a good article link you’d like to share?
Start tweeting with the hashtag #CHESTPulmVasc